InnovationScienceTechnology

Scientists Discover Enzyme’s Dual Role in Fat Regulation, Opening New Avenues for Obesity Therapy

Scientists have uncovered a surprising dual function for a key fat-metabolizing enzyme that operates both as a fat-breaker and gene regulator. This discovery helps explain why people with mutations in this enzyme develop lipodystrophy rather than obesity and could lead to new therapeutic strategies for metabolic disorders.

Enzyme’s Unexpected Dual Function Revealed

Scientists have discovered that a well-known fat-digesting enzyme plays a surprising second role as a genetic regulator within fat cells, according to a new study published in Cell Metabolism. The research reveals that hormone-sensitive lipase (HSL), previously understood only as an enzyme that breaks down stored fat, also enters cell nuclei to control gene activity that maintains healthy fat tissue structure.

BusinessEconomyHealthcare

Danish Economic Sentiment Sours as Novo Nordisk Shares Plunge, Watchdog Warns

Denmark’s economic outlook faces headwinds as Novo Nordisk’s stock slump impacts consumer sentiment. The fiscal watchdog suggests the pharmaceutical giant’s downturn may distort perceptions of the broader economy’s health.

Pharmaceutical Giant’s Stock Decline Impacts National Mood

Denmark’s consumer confidence faces additional pressure from Novo Nordisk’s declining stock performance, with the pharmaceutical company’s slumping shares potentially deepening economic pessimism and obscuring the economy’s actual strength, according to reports from the country’s fiscal watchdog.